高龄老人中认知与痴呆同阿尔茨海默病及其他病变神经病理改变的关联
基于「90+研究」367例尸检脑组织,评估高龄老人阿尔茨海默病神经病理改变(ADNC)与非ADNC共病的患病率及其与生前认知的关联。总神经病理负荷、β-淀粉样蛋白、神经原纤维缠结和LATE-NC均与痴呆 odds 升高相关;对ADNC/PART的抵抗罕见(3%),而韧性常见(55%),非ADNC共病存在时韧性更少见。
要点
- 总神经病理负荷、β-淀粉样蛋白、神经原纤维缠结和LATE-NC均与痴呆 odds 升高相关。
- LATE-NC在伴与不伴海马硬化时均与痴呆相关,并增加ADNC者痴呆 odds。
- 对中/重度ADNC/PART的抵抗罕见(3%),而韧性常见(55%)。
核心结论
- 非ADNC神经病理共病(以LATE-NC为主)对高龄老人认知有重要影响。
- 鉴于非ADNC共病神经病理异常的累积效应,降低其患病率(尤其LATE-NC)对减少高龄老人痴呆负担至关重要。
研究设计与样本
- 「90+研究」是一项在高龄老人中开展的老龄化/痴呆纵向人群研究。
- 纳入同意死后脑检查的参与者,截至2020年12月所有尸检脑组织均接受评估。
- 样本量 n=367,评估ADNC和非ADNC神经病理共病的患病率。
- 采用多项logistic回归和多元线性回归评估神经病理病变或总神经病理负荷评分与认知的关联。
主要发现
- 样本中最常见的神经病理特征为ADNC/PART相关。
- 痴呆 odds 升高与总神经病理负荷升高相关(OR 1.5,95% CI 1.3-1.7,p<0.0001)。
- 痴呆 odds 升高与β-淀粉样蛋白相关(OR 1.6,95% CI 1.2-2.0,p<0.0001)。
- 痴呆 odds 升高与神经原纤维缠结相关(OR 2.6,95% CI 1.7-4.1,p<0.0001)。
- 痴呆 odds 升高与LATE-NC相关(OR 2.3,95% CI 1.7-3.1,p<0.0001)。
关键数值与推荐
- LATE-NC与伴海马硬化的痴呆相关(OR 6.1,95% CI 2.0-18.7,p=0.002)。
- LATE-NC与不伴海马硬化的痴呆相关(OR 5.0,95% CI 2.6-9.7,p<0.0001)。
- LATE-NC增加ADNC参与者痴呆 odds(OR 5.0,95% CI 2.7-9.2,p<0.0001)。
- 对中/重度ADNC/PART的抵抗罕见(3%),对ADNC/PART的韧性常见(55%)。
- 中/重度ADNC/PART者中,每增加一个非ADNC共病病变痴呆 odds 升高(1个病变:OR 2.4,95% CI 1.3-4.5,p<0.005;2个病变:OR 5.9,95% CI 2.8-12.3,p<0.0001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Age is the largest risk factor for dementia. However, dementia is not universal, even among the oldest-old age groups. Following contemporary neuropathologic guidelines, our objectives were to describe the key neuropathologic lesions and their associations with antemortem cognition in oldest-old individuals. METHODS: Participants were those enrolled in The 90+ Study, a longitudinal, population-based study of aging/dementia in the oldest old, who agreed to postmortem brain examination. All autopsied brains as of December 2020 were evaluated for the prevalence of Alzheimer disease neuropathologic change (ADNC) and non-ADNC neuropathologic comorbidities. Associations between neuropathologic lesions or the total neuropathologic burden score (sum of the individual scores) and cognition were assessed using multinomial logistic regression and multiple linear regression. Separate regression analyses evaluated relationships between limbic-predominant age-related TDP-43 encephalopathy (LATE-NC) and hippocampal sclerosis (HS) or ADNC/primary age-related tauopathy (PART). Resistance, or failure to develop ADNC/PART, and resilience, inferred from higher-than-expected cognitive functioning, were evaluated in the presence or absence of non-ADNC neuropathologic features. RESULTS: The most common neuropathologic features in the sample (n = 367) were ADNC/PART related. Increased dementia odds were associated with elevated total neuropathologic burden (odds ratio [OR] 1.5, 95% CI 1.3-1.7, p < 0.0001), β-amyloid (OR 1.6, 95% CI 1.2-2.0, p < 0.0001), neurofibrillary tangles (OR 2.6, 95% CI 1.7-4.1, p < 0.0001), and LATE-NC (OR 2.3, 95% CI 1.7-3.1, p < 0.0001), correcting for multiple comparisons. LATE-NC was associated with dementia with (OR 6.1, 95% CI 2.0-18.7, p = 0.002) and without (OR 5.0, 95% CI 2.6-9.7, p < 0.0001) co-occurring HS and increased the odds of dementia among participants with ADNC (OR 5.0, 95% CI 2.7-9.2, p < 0.0001). Resistance to moderate/severe ADNC/PART was rare (3%), but resilience to ADNC/PART was not (55%). Resilience was rarer in the presence of non-ADNC comorbid lesions, particularly LATE-NC. Among those with moderate/severe ADNC/PART, dementia odds increased with each non-ADNC comorbid lesion (e.g., 1 lesion: OR 2.4, 95% CI 1.3-4.5, p < 0.005; 2 lesions: OR 5.9, 95% CI 2.8-12.3, p < 0.0001). DISCUSSION: These results highlight the importance of non-ADNC neuropathologic comorbidity, predominantly LATE-NC, to cognition in the oldest old. Given the cumulative effects of non-ADNC comorbid neuropathologic abnormalities, reducing their prevalence, especially LATE-NC, will be vital to the ultimate goal of reducing dementia burden in the oldest-old individuals.
引用
- Montine TJ, Corrada MM, Kawas C, et al. Association of Cognition and Dementia With Neuropathologic Changes of Alzheimer Disease and Other Conditions in the Oldest Old. Neurology. 2022. PMID: 35705500. doi:10.1212/WNL.0000000000200832
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。